Vaxcyte, Inc. Contracts & Agreements

57 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Vaxcyte, Inc. 2020 Equity Incentive Plan and forms of agreements thereunder
Bonus & Incentive Agreements
Vaxcyte, Inc.
Biotechnology
DE
2020
Form of Pre-Funded Warrant
Warrant Agreements
Vaxcyte, Inc.
2024
Underwriting Agreement, dated September 4, 2024
Underwriting Agreements
Vaxcyte, Inc.
2024
Form of Non. U.S. Restricted Stock Unit Grant Notice (2020 Equity Incentive Plan)
Bonus & Incentive Agreements
Vaxcyte, Inc.
2024
Form of Non-U.S. Stock Option Grant Notice and Stock Option Agreement (2020 Equity Incentive Plan)
Bonus & Incentive Agreements
Vaxcyte, Inc.
2024
First Amendment to Lease Agreement by and between the Registrant and ARE-San Francisco No. 63, LLC, dated October 17, 2023
Lease Agreements
Vaxcyte, Inc.
2024
First Amendment to License Agreement by and between the Registrant and The Regents of the University of California, represented by its San Diego campus, dated August 16, 2019
License Agreements
Vaxcyte, Inc.
2024
Manufacturing Rights Agreement by and between the Registrant and Sutro Biopharma, Inc., dated November 21, 2023
Vaxcyte, Inc.
2024
Commercial Manufacturing and Supply Agreement by and between the Registrant and Lonza Ltd., dated October 13, 2023
Supply Agreements
Vaxcyte, Inc.
2024
Master Services Agreement for Drug Product Development and Manufacturing between Registrant and Lonza Ltd., dated March 22, 2022, as amended
Development Agreements
Vaxcyte, Inc.
2024
Form of Pre-Funded Warrant
Warrant Agreements
Vaxcyte, Inc.
2024
Underwriting Agreement, dated January 30, 2024
Underwriting Agreements
Vaxcyte, Inc.
2024
Assignment and Assumption of Lease Agreement by and between the Registrant and Codexis, Inc., dated September 1, 2023
Lease Agreements
Vaxcyte, Inc.
2023
Consent to Assignment and First Amendment by and among ARE-San Francisco No. 63, LLC, Codexis, Inc. and the Registrant, dated September 6, 2023
Assignment Agreements
Vaxcyte, Inc.
2023
Third Amendment to Amended and Restated SutroVax Agreement by and between Sutro Biopharma, Inc. and the Registrant, dated September 28, 2023
Vaxcyte, Inc.
2023
Form of Stock Option Grant Notice and Stock Option Agreement
Stock Agreements
Vaxcyte, Inc.
2023
Vaxcyte, Inc. 2020 Equity Incentive Plan
Bonus & Incentive Agreements
Vaxcyte, Inc.
2023
Form of Pre-Funded Warrant
Warrant Agreements
Vaxcyte, Inc.
Biotechnology
NY
2023
Underwriting Agreement, dated April 18, 2023
Underwriting Agreements
Vaxcyte, Inc.
2023
Amendment No. 1 to Sales Agreement, dated February 27, 2023, by and between Vaxcyte, Inc. and Jefferies LLC
Sales Agreements
Vaxcyte, Inc.
2023
Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd., dated October 21, 2016, as amended
Development Agreements
Vaxcyte, Inc.
2022
Form of Pre-Funded Warrant
Warrant Agreements
Vaxcyte, Inc.
2022
Underwriting Agreement, dated October 25, 2022
Underwriting Agreements
Vaxcyte, Inc.
2022
Master Services Agreement for Drug Product Development and Manufacturing between the Registrant and Lonza Ltd., dated March 22, 2022, as amended
Development Agreements
Vaxcyte, Inc.
2022
Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd., dated October 21, 2016, as amended
Development Agreements
Vaxcyte, Inc.
2022
Form of Restricted Stock Unit Grant Notice
Stock Agreements
Vaxcyte, Inc.
2022
Offer Letter entered into by and between the Registrant and Mikhail Eydelman, dated March 4, 2022
Vaxcyte, Inc.
2022
Form of Pre-Funded Warrant
Warrant Agreements
Vaxcyte, Inc.
Biotechnology
NY
2022
Underwriting Agreement, dated January 12, 2022
Underwriting Agreements
Vaxcyte, Inc.
Biotechnology
NY
2022
Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd., dated October 21, 2016, as amended
Development Agreements
Vaxcyte, Inc.
Biotechnology
2021
Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd, dated October 21, 2016, as amended
Development Agreements
Vaxcyte, Inc.
Biotechnology
2021
Description of Capital Stock
Stock Agreements
Vaxcyte, Inc.
2021
Lease Agreement by and between the Company and ARE-San Francisco No. 63, LLC, dated as of January 21, 2021
Lease Agreements
Vaxcyte, Inc.
2021
Vaxcyte, Inc. 2020 Employee Stock Purchase Plan
Stock Agreements
Vaxcyte, Inc.
2020
Form of common stock certificate of the Registrant
Stock Agreements
Vaxcyte, Inc.
2020
Form of Underwriting Agreement
Underwriting Agreements
Vaxcyte, Inc.
2020
Offer Letter entered into by and between the Registrant and Andrew Guggenhime, dated April 16, 2020
Vaxcyte, Inc.
Biotechnology
CA
2020
Vaxcyte, Inc. Amended and Restated 2014 Equity Incentive Plan and forms of agreements thereunder
Bonus & Incentive Agreements
Vaxcyte, Inc.
Biotechnology
DE
2020
Offer Letter entered into by and between the Registrant and Jane Wright-Mitchell, dated December 6, 2018
Vaxcyte, Inc.
2020
Executive Employment Agreement entered into by and between the Registrant and Jim Wassil, dated November 15, 2019
Employment Agreements
Vaxcyte, Inc.
2020
Separation Agreement and Release entered into by and between the Registrant and Elaine Sun, dated December 17, 2019
Separation Agreements
Vaxcyte, Inc.
2020
Executive Employment Agreement entered into by and between the Registrant and Elaine Sun, dated January 1, 2017
Employment Agreements
Vaxcyte, Inc.
Biotechnology
CA
2020
Offer Letter entered into by and between the Registrant and Paul Sauer, dated April 12, 2016
Vaxcyte, Inc.
Biotechnology
2020
Executive Employment Agreement entered into by and between the Registrant and Jeff Fairman, dated January 21, 2016
Employment Agreements
Vaxcyte, Inc.
2020
Executive Employment Agreement entered into by and between the Registrant and Grant Pickering, dated January 21, 2016
Employment Agreements
Vaxcyte, Inc.
2020
Form of Indemnification Agreement to be entered into by and between the Registrant and each director and executive officer
Indemnification Agreements
Vaxcyte, Inc.
Biotechnology
DE
2020
Amended and Restated Investors Rights Agreement by and among the Registrant and certain of its stockholders, dated March 20, 2020
Investor Rights Agreements
Vaxcyte, Inc.
Biotechnology
DE
2020
Form of Executive Change in Control and Severance Agreement to be entered into by and between the Registrant and each eligible employee
Change of Control Agreements
Vaxcyte, Inc.
2020
Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd, dated October 29, 2018
Development Agreements
Vaxcyte, Inc.
2020
Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd, dated October 21, 2016, as amended
Development Agreements
Vaxcyte, Inc.
2020
Letter Agreement by and between the Registrant and Lonza Ltd, dated June 19, 2018
Vaxcyte, Inc.
Biotechnology
2020
Amended and Restated SutroVax Agreement by and between the Registrant and Sutro Biopharma, Inc., dated October 12, 2015, as amended
Vaxcyte, Inc.
Biotechnology
2020
Supply Agreement by and between the Registrant and Sutro Biopharma, Inc., dated May 29, 2018
Supply Agreements
Vaxcyte, Inc.
Biotechnology
DE
2020
License Agreement by and between the Registrant and The Regents of the University of California, represented by its San Diego campus, dated February 4, 2019
License Agreements
Vaxcyte, Inc.
Biotechnology
CA
2020
Lease Agreement by and among the Registrant, Grey Peak Fork, LLC and Grey Peak Fork, Series A, LLC, dated July 22, 2016
Lease Agreements
Vaxcyte, Inc.
2020
Assignment and Assumption of Lease and Consent of Lessor by and among the Registrant, Orchard Therapeutics North America and Rakesh Kumar and Premila Kumar Revocable Family Trust,...
Lease Agreements
Vaxcyte, Inc.
2020
Third Addendum to Standard Multi-Tenant Office Lease by and between the Registrant and Rakesh Kumar and Premila Kumar Revocable Family Trust, dated July 1, 2019
Lease Agreements
Vaxcyte, Inc.
Biotechnology
2020